These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10922458)

  • 1. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox.
    Tsikas D; Böger RH; Sandmann J; Bode-Böger SM; Frölich JC
    FEBS Lett; 2000 Jul; 478(1-2):1-3. PubMed ID: 10922458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
    Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
    Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous production of nitric oxide synthase inhibitors.
    Anthony S; Leiper J; Vallance P
    Vasc Med; 2005 Jul; 10 Suppl 1():S3-9. PubMed ID: 16444863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
    Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.
    Leiper J; Vallance P
    Cardiovasc Res; 1999 Aug; 43(3):542-8. PubMed ID: 10690326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases.
    Kittel A; Maas R
    Curr Pharm Des; 2014; 20(22):3530-47. PubMed ID: 24180385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase inhibitors and cerebral vasospasm.
    Jung CS
    Acta Neurochir Suppl; 2011; 110(Pt 1):87-91. PubMed ID: 21116921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
    Caplin B; Leiper J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1343-53. PubMed ID: 22460557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia.
    Lücke T; Tsikas D; Kanzelmeyer N; Vaske B; Das AM
    Metabolism; 2006 Dec; 55(12):1599-603. PubMed ID: 17142130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat.
    Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H
    Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury.
    Cardounel AJ; Zweier JL
    J Biol Chem; 2002 Sep; 277(37):33995-4002. PubMed ID: 12091378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin.
    Cardounel AJ; Xia Y; Zweier JL
    J Biol Chem; 2005 Mar; 280(9):7540-9. PubMed ID: 15574418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of accumulated endogenous nitric oxide synthase inhibitors and decreased nitric oxide synthase activity for impaired trigonal relaxation with ischemia.
    Masuda H; Yano M; Sakai Y; Kihara K; Goto M; Azuma H
    J Urol; 2003 Oct; 170(4 Pt 1):1415-20. PubMed ID: 14501780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA.
    Matsuura C; Moraes TL; Barbosa JB; Moss MB; Siqueira MA; Mann GE; Neto ML; Brunini TM; Mendes-Ribeiro AC
    Trans R Soc Trop Med Hyg; 2012 Mar; 106(3):174-9. PubMed ID: 22284722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylarginines in Mice with Experimental Atherosclerosis.
    Gilinsky MA; Sukhovershin RA; Cherkanova MS
    Bull Exp Biol Med; 2015 Nov; 160(1):13-6. PubMed ID: 26601840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The arginine paradox].
    Nakaki T; Hishikawa K
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):7-14. PubMed ID: 11862757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformationally-restricted arginine analogues as alternative substrates and inhibitors of nitric oxide synthases.
    Lee Y; Marletta MA; Martasek P; Roman LJ; Masters BS; Silverman RB
    Bioorg Med Chem; 1999 Jun; 7(6):1097-104. PubMed ID: 10428379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.